Revisiting the role of ABC transporters in multidrug-resistant cancer
2018 · Nature reviews. Cancer · 1,767 citations
https://doi.org/10.1038/s41568-018-0005-8
M
Michael M. Gottesman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
698
Papers
65.0K
Citations
107
h-index
368
i10-index
Michael M. Gottesman is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Drug Transport and Resistance Mechanisms & RNA Interference and Gene Delivery & Cancer therapeutics and mechanisms. The author has an h-index of 107, co-authored 594 publications.
ORCID: 0000-0001-8908-2097Papers by this author
worksMechanisms of Multidrug Resistance in Cancer
2009 · Methods in molecular biology · 678 citations
https://doi.org/10.1007/978-1-60761-416-6_4
Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity
2016 · Journal of Biological Chemistry · 180 citations
https://doi.org/10.1074/jbc.m116.755884
The Inhibitor Ko143 Is Not Specific for ABCG2
2015 · Journal of Pharmacology and Experimental Therapeutics · 135 citations
https://doi.org/10.1124/jpet.115.225482
Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells
2003 · Genome biology · 106 citations
https://doi.org/10.1186/gb-2003-4-12-r82
Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines
2003 · British Journal of Cancer · 89 citations
https://doi.org/10.1038/sj.bjc.6600861
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat